Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
56%
OVERLAP
BY WEIGHT
25
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
23%
ALSO IN HRTS
HRTS
44
HOLDINGS
57%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.5% | 10.1% | 10.1% |
|
JOHNSON & JOHNSON | 6.1% | 4.0% | 4.0% |
|
UNITEDHEALTH GROUP INC | 3.9% | 4.5% | 3.9% |
 |
ASTRAZENECA PLC | 3.6% | 4.3% | 3.6% |
|
MERCK & CO. INC. | 3.4% | 4.0% | 3.4% |
IXJ Overweight Relative to HRTS
 |
ROCHE HOLDING LTD | 3.7% |
|
JOHNSON & JOHNSON | 2.1% |
|
ABBVIE INC | 2.0% |
|
PFIZER INC | 1.8% |
|
STRYKER CORP | 1.6% |
 |
SANOFI-AVENTIS | 1.3% |
|
GSK PLC | 1.3% |
|
CVS CAREMARK CORP | 1.3% |
|
ESSILOR INTERNATIONAL | 1.2% |
|
ELEVANCE HEALTH INC | 1.0% |
IXJ Underweight Relative to HRTS
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
REVOLUTION MEDICINES, INC. | -2.8% |
|
BRIDGEBIO PHARMA, INC. | -2.2% |
|
CYTOKINETICS INC | -1.5% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.4% |
|
ALNYLAM PHARMACEUTICALS INC | -1.4% |
|
BOSTON SCIENTIFIC CORP | -1.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -1.3% |
|
VERTEX PHARMACEUTICALS INC | -1.3% |
 |
MEDTRONIC PLC | -1.3% |